Plasma syndecan-1 concentration as a biomarker for endothelial glycocalyx degradation in septic adult horses
- PMID: 35842924
- DOI: 10.1111/evj.13862
Plasma syndecan-1 concentration as a biomarker for endothelial glycocalyx degradation in septic adult horses
Erratum in
-
Correction to "Plasma syndecan-1 concentration as a biomarker for endothelial glycocalyx degradation in septic adult horses".Equine Vet J. 2025 Jan;57(1):282. doi: 10.1111/evj.14441. Epub 2024 Nov 26. Equine Vet J. 2025. PMID: 39588632 No abstract available.
Abstract
Background: Limited information is available regarding endothelial glycocalyx degradation during sepsis in horses. Plasma syndecan-1 concentrations are increased in consequence of sepsis in other species and have been useful for prognostication.
Objectives: To determine whether plasma syndecan-1 levels are increased in adult horses affected with sepsis.
Study design: Retrospective cohort study.
Methods: Adult horses were assigned to one of three groups based on results of physical and laboratory examinations, clinical diagnosis, and results of previously described SIRS classification: Group 1 horses included healthy, nonseptic horses; Group 2 included horses in which clinical illness was identified but that were not considered to be septic; Group 3 included horses with a clinical diagnosis of sepsis. Plasma syndecan-1 concentration was determined in blood obtained at admission into the hospital for each horse, using an equine specific ELISA. Data were analysed using ANOVA and linear regression (p ≤ 0.05).
Results: One hundred and ninety-one horses were included and divided into three groups. Scores for SIRS were highest for Group 3 horses and lowest in Groups 1 and 2. Plasma syndecan-1 concentrations in Group 3 horses (50.73 ± 84.24 μg/ml; n = 42) were greater than those for Group 1 (15.69 ± 11.28 μg/ml; n = 66) and Group 2 (16.88 ± 15.30 μg/ml; n = 83). There was no difference regarding syndecan concentrations between Groups 1 and 2.
Main limitations: Retrospective study design, solitary time point of measurement for each patient, and lack of a widely accepted consensus regarding definitive diagnosis of sepsis in adult horses.
Conclusions: Circulating plasma levels of syndecan-1, a biochemical marker of endothelial glycocalyx damage, are increased in septic adult horses.
Keywords: endothelial glycocalyx; horse; sepsis; syndecan-1.
© 2022 EVJ Ltd.
References
REFERENCES
-
- Murphy LS, Wickersham N, McNeil JB, Shaver CM, May AK, Bastarache JA, et al. Endothelial glycocalyx degradation is more severe in patients with non-pulmonary sepsis compared to pulmonary sepsis and associates with risk of ARDS and other organ dysfunction. Ann Intensive Care. 2017;7:102-10.
-
- Lipowsky HH. The endothelial glycocalyx as a barrier to leukocyte adhesion and its mediation by extracellular proteases. Ann Biomed Eng. 2012;40:840-8.
-
- Schmidt EP, Yang Y, Janssen WJ, Gandjeva A, Perez MJ, Barthel L, et al. The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis. Nat Med. 2012;18:1217-23.
-
- Woodcock TE, Woodcock TM. The revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth. 2012;108:384-94.
-
- Yang Y, Schmidt EP. The endothelial glycocalyx: an important regulator of the pulmonary vascular barrier. Tissue Barriers. 2013;1:e23494.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical